GHA
ARNA

GW Henssler & Associates’s Arena Pharmaceuticals Inc ARNA Stock Holding History

GW Henssler & Associates’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-1,056
Closed -$56K – 174
2013
Q3 		$56K Sell
1,056
-210
-17% -$14.1K 0.01% 156
2013
Q2 		$98K Buy
+1,266
New +$103K 0.01% 144

Other funds holding ARNA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 17.47% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
SC
Samlyn Capital New York $5.86B AUM 36.3% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

GW Henssler & Associates's ARNA Position: Q4 2013 in Review

GW Henssler & Associates sold out of Arena Pharmaceuticals Inc (ARNA) in Q4 2013, closing a stake of 1,056 shares — an estimated $56K sold.

GW Henssler & Associates first reported a position in ARNA in Q2 2013 and held it in 2 quarters. The position peaked at $98K in Q2 2013. 134 funds tracked by Wall St. Rank hold ARNA as of Q4 2013.

  • GW Henssler & Associates reported no remaining Arena Pharmaceuticals Inc position as of Q4 2013 after selling out during the quarter.
  • GW Henssler & Associates sold 1,056 Arena Pharmaceuticals Inc shares in Q4 2013, an estimated $56K.
  • GW Henssler & Associates first reported a position in Arena Pharmaceuticals Inc in Q2 2013 and held it in 2 quarters.
  • GW Henssler & Associates's Arena Pharmaceuticals Inc position peaked at $98K in Q2 2013.
  • 134 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q4 2013.

Based on GW Henssler & Associates's 13F filing for Q4 2013, filed 7 Feb 2014.